Acessibilidade / Reportar erro

Urine Pregnancy Test before Rubella Vaccination among Reproductive Age Females: An Observation

Teste de gravidez por urina antes de vacinação contra rubéola em mulheres com idade fértil: uma observação

Dear Editor,

Rubella is an important concern in obstetrics. It is a viral illness presenting with fever and skin rash. In a previous report on a seroprevalence study among pregnant women by Ferezin et al11 Ferezin RI, Bertolini DA, Demarchi IG. [Prevalence of positive sorology for HIV, hepatitis B, toxoplasmosis and rubella in pregnant women fromthe northwestern region of the state of Paraná]. Rev Bras Ginecol Obstet. 2013;35(2):66-70, “no patient was positive for IgM, and IgG reactivity was 99.6%.” It should be noted that rubella is an extremely undesirable problem during pregnancy. Thus, the vaccine should be given prior to pregnancy. Nevertheless, an important concern is the contraindication of rubella vaccine for pregnant women.22 Bhatt B, Jindal H, Malik JS, Choudhry S. Vaccination for pregnant women: need to address. Hum Vaccin Immunother 2014;10(12): 3627-3628 As a rule, there should be confirmation of no pregnancy before the physician can prescribe a rubella vaccine to a reproductive age female patient. Here, we share our experience from our perspective regarding the issue. The authors review results from urine pregnancy test screening before rubella vaccination among reproductive age females from 184 cases visiting our center seeking vaccination. All cases were healthy and mentioned no missed menstruation. Of the 184 cases, two (1.09%) refused to undergo the urine pregnancy test and no further vaccination was considered. Focusing on the remaining 182 cases, positive urine pregnancy was seen in two cases (1.09%) and no further vaccination was considered. Of interest, there are some pregnancy cases detected by the screening confirming the need for urine pregnancy test screening. Although the patients give clear history of no symptoms of pregnancy, this can sometimes be bias or in disguise. In addition, some patients might reject screening and it is not possible to give vaccine in such cases.

References

  • 1
    Ferezin RI, Bertolini DA, Demarchi IG. [Prevalence of positive sorology for HIV, hepatitis B, toxoplasmosis and rubella in pregnant women fromthe northwestern region of the state of Paraná]. Rev Bras Ginecol Obstet. 2013;35(2):66-70
  • 2
    Bhatt B, Jindal H, Malik JS, Choudhry S. Vaccination for pregnant women: need to address. Hum Vaccin Immunother 2014;10(12): 3627-3628

Publication Dates

  • Publication in this collection
    Mar 2016

History

  • Received
    13 Oct 2015
  • Accepted
    21 Dec 2015
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia Av. Brigadeiro Luís Antônio, 3421, sala 903 - Jardim Paulista, 01401-001 São Paulo SP - Brasil, Tel. (55 11) 5573-4919 - Rio de Janeiro - RJ - Brazil
E-mail: editorial.office@febrasgo.org.br